Celsense - Press Releases

 

 

Celsense News - Press Releases

02-01-14
Celsense, Inc Board of Directors Elects Gregory T. Hebrank M.D. to Board

10-03-13
Celsense, Inc. to Give Company Presentation at the Stem Cell Meeting on the Mesa

06-03-13
Celsense, Inc Director Ronald B. Herberman Dies at 72

05-23-13
The Maryland Stem Cell Research Fund Awards Two Year Grant to Fund Clinical MRI Cell Tracking Using Celsense Technology

04-11-13
The First Patient Treated Using Celsense MRI Cell Tracking Technology

01-21-13
Launch of Dual-Mode Near-Infrared Probe for Imaging Inflammation by MRI and Optical Approaches

12-17-12
Study Using a Novel MRI-based Probe to Image Inflammatory Cells in Cancer is Published in OncoImmunology

08-31-12
Publication in Cell Transplantation Indicates That Cell Sense Does Not Affect Differentiation In Vivo

08-24-12
Celsense, Inc Files Health Canada Regulatory Submission

07-20-12
Journal of Inflammation Article Demonstrates Utility of V-Sense in Drug Development

07-18-12
Celsense, Inc. Launches Product Upgrades for Voxel Tracker ®

05-03-12
Additional Patents for Cell Sense Issued by the USPTO

12-20-11
Celsense, Inc. is Issued Patent for MRI Cell Tracking Product

08-20-11
Celsense, Inc. Launches a New Dual-mode Imaging Agent Enabling Inflammation Detection by MRI and Fluorescence

06-27-11
Celsense, Inc. Announces First Clinical Trial Authorization by the US Food and Drug Administration (FDA) for Use of Its Cell Tracking Imaging Product Cell Sense

05-10-11
The First IND Submitted to the US Food and Drug Administration Using Cell Sense in a Clinical Trial

04-20-2011
Celsense, Inc. Announces Patent Issued For New MRI Reporter Gene

11-02-10
Celsense, Inc. Completes Sale of Series C Shares

03-18-10
Novel Imaging Software Released by Celsense, Inc.

01-19-10
Celsense, Inc. Launches a Dual–Mode Imaging Reagent Enabling Cell Detection by MRI and Fluorescence

01-11-10
New Journal Article Offers In-Depth Analysis of Biological Impact of Celsense’s Cell Labeling Product on Human Dendritic Cells

10-19-09
Celsense, Inc Receives Funding to Develop Dual Mode Imaging Agent

10-12-09
Celsense, Inc Files FDA and EMEA Regulatory Submissions

7-2-09
Celsense, Inc Raises Additional Funds in Series B

6-2-09
Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use

5-19-09
Celsense, Inc. Opens New R&D Facility

4-30-09
Celsense to Present Use of in vivo Cellular Imaging Technology with Human at International Cell Therapy Conference

4-15-09
Celsense Technologies Featured in Multiple Presentations at Upcoming Imaging Conference

4-9-09
Celsense to Present in vivo Cellular Imaging Technology at AACR as Potential Tool in Treatment of Cancer

7-23-08
Celsense, Inc. Announces New Product Release

5-2-08
Celsense, Inc. Announces Strategic Alliance with m2m Imaging

3-22-08
Celsense, Inc. Announces Sale of Series B Shares

3-22-08
Celsense, Inc. Announces Exhibit at 2008 ISMRM Conference

2-15-08
Celsense, Inc. Announces SBIR Award

10-4-07
Celsense, Inc. Announces New Product

7-22-07
Celsense, Inc. Announces First Product Sales

7-16-07
Celsense, Inc. Completes Second Series A Financing

9-14-06
Celsense, Inc. CSO Presents at Stem Cell Conference

8-14-06
Celsense, Inc. Completes $625,000 Series A Funding

12-15-05
Celsense, Inc. Completes Licensing Agreements with Carnegie Mellon University